Author:
Boucek Jan A.,Turner J. Harvey
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference21 articles.
1. Turner JH, Martindale AA, Boucek J, Claringbold PG, Leahy MF. 131I-Anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkin?s lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital. Cancer Biother Radiopharm 2003;18:513?24.
2. Wahl RL. Iodine-131 anti-B1 antibody therapy in non-Hodgkin?s lymphoma: dosimetry and clinical implications. J Nucl Med 1998;39(suppl):1S?9S.
3. Wahl RL, Kroll S, Zasadny KR. Patient-specific whole-body dosimetry: principles and a simplified method for clinical implementation. J Nucl Med 1998;39(suppl):9S?16S.
4. Wiseman GA, Leigh B, Lamonica D, Kornmehl E, Spies SM, Silverman DHS, et al. Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphoma. Cancer 2002;94:1349?57.
5. DeNardo SJ, DeNardo GL, Kukis D, Shen S, Kroger L, DeNardo DA, et al. 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumour regression in patients with lymphoma. J Nucl Med 1999;40:303?10
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献